HEALTH AND HAPPINESS (H&H) INTERNATIONAL HOLDINGS LIMITED Financials Health and Happiness (H&H) International Holdings Limited
Equities
1112
KYG4387E1070
Food Processing
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.22 HKD | +1.59% |
|
+1.39% | -15.54% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 18,541 | 15,567 | 6,351 | 9,499 | 7,100 | 6,107 | - | - |
| Enterprise Value (EV) 1 | 22,363 | 19,760 | 13,429 | 16,763 | 14,772 | 12,968 | 12,332 | 11,704 |
| P/E ratio | 18.4 x | 13.7 x | 12.5 x | 15.5 x | 12.2 x | 7.03 x | 5.73 x | 5.15 x |
| Yield | 2.7% | 3.54% | 4.46% | 3.75% | 5.2% | 7.42% | 9.17% | 8.89% |
| Capitalization / Revenue | 1.7 x | 1.39 x | 0.55 x | 0.74 x | 0.51 x | 0.41 x | 0.38 x | 0.36 x |
| EV / Revenue | 2.05 x | 1.77 x | 1.16 x | 1.31 x | 1.06 x | 0.87 x | 0.77 x | 0.69 x |
| EV / EBITDA | 10 x | 9.15 x | 7.25 x | 8.5 x | 6.67 x | 5.61 x | 4.9 x | 4.32 x |
| EV / FCF | 16.8 x | 13.6 x | 7.5 x | 11.8 x | 14.2 x | 7.08 x | 7.02 x | 5.65 x |
| FCF Yield | 5.97% | 7.34% | 13.3% | 8.5% | 7.03% | 14.1% | 14.2% | 17.7% |
| Price to Book | 3.3 x | 2.51 x | 1.08 x | 1.53 x | 1.12 x | 0.88 x | 0.81 x | 0.75 x |
| Nbr of stocks (in thousands) | 643,326 | 644,433 | 645,211 | 645,561 | 645,561 | 645,561 | - | - |
| Reference price 2 | 28.82 | 24.16 | 9.843 | 14.71 | 11.00 | 9.460 | 9.460 | 9.460 |
| Announcement Date | 3/23/20 | 3/23/21 | 3/22/22 | 3/21/23 | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 10,925 | 11,195 | 11,548 | 12,776 | 13,926 | 14,911 | 15,994 | 16,985 |
| EBITDA 1 | 2,235 | 2,161 | 1,852 | 1,972 | 2,216 | 2,312 | 2,516 | 2,706 |
| EBIT 1 | 2,030 | 1,951 | 1,546 | 1,578 | 1,724 | 1,987 | 2,197 | 2,441 |
| Operating Margin | 18.58% | 17.43% | 13.39% | 12.35% | 12.38% | 13.33% | 13.74% | 14.37% |
| Earnings before Tax (EBT) 1 | 1,565 | 1,605 | 850.2 | 1,031 | 933.6 | 1,350 | 1,642 | 1,857 |
| Net income 1 | 1,005 | 1,137 | 508.5 | 611.8 | 581.8 | 869.5 | 1,073 | 1,187 |
| Net margin | 9.2% | 10.15% | 4.4% | 4.79% | 4.18% | 5.83% | 6.71% | 6.99% |
| EPS 2 | 1.570 | 1.760 | 0.7900 | 0.9500 | 0.9000 | 1.347 | 1.652 | 1.836 |
| Free Cash Flow 1 | 1,334 | 1,451 | 1,790 | 1,424 | 1,039 | 1,832 | 1,756 | 2,070 |
| FCF margin | 12.21% | 12.96% | 15.5% | 11.15% | 7.46% | 12.29% | 10.98% | 12.19% |
| FCF Conversion (EBITDA) | 59.69% | 67.17% | 96.64% | 72.24% | 46.89% | 79.25% | 69.79% | 76.5% |
| FCF Conversion (Net income) | 132.76% | 127.67% | 351.96% | 232.83% | 178.53% | 210.71% | 163.58% | 174.47% |
| Dividend per Share 2 | 0.7771 | 0.8557 | 0.4391 | 0.5522 | 0.5720 | 0.7017 | 0.8679 | 0.8409 |
| Announcement Date | 3/23/20 | 3/23/21 | 3/22/22 | 3/21/23 | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 Q3 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 5,830 | 5,167 | 6,027 | 5,424 | 6,124 | 5,955 | 6,820 | 6,981 | 3,298 | 6,946 |
| EBITDA | - | - | 973 | - | - | - | - | - | - | 906 |
| EBIT | - | - | 897.2 | 929.7 | 616.7 | 900.8 | 644.3 | 1,160 | - | 564.7 |
| Operating Margin | - | - | 14.88% | 17.14% | 10.07% | 15.13% | 9.45% | 16.61% | - | 8.13% |
| Earnings before Tax (EBT) | - | - | 608.5 | - | - | - | - | - | - | 30.45 |
| Net income | - | - | 418.7 | 501.4 | 7.13 | 475.1 | - | - | - | -26.17 |
| Net margin | - | - | 6.95% | 9.24% | 0.12% | 7.98% | - | - | - | -0.38% |
| EPS | - | - | - | - | - | 0.7400 | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/23/20 | 8/25/20 | 3/23/21 | 8/24/21 | 3/22/22 | 8/29/22 | 3/21/23 | 8/22/23 | 12/26/23 | 3/26/24 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 3,821 | 4,193 | 7,078 | 7,265 | 7,673 | 6,861 | 6,225 | 5,597 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.709 x | 1.941 x | 3.822 x | 3.684 x | 3.463 x | 2.968 x | 2.474 x | 2.068 x |
| Free Cash Flow 1 | 1,334 | 1,451 | 1,790 | 1,424 | 1,039 | 1,832 | 1,756 | 2,071 |
| ROE (net income / shareholders' equity) | 19.2% | 19.3% | 15.8% | 10.2% | 9.36% | 12.8% | 14.7% | 15.1% |
| ROA (Net income/ Total Assets) | 6.54% | 6.87% | 5.08% | 2.97% | 2.84% | 4.2% | 5.27% | 5.38% |
| Assets 1 | 15,358 | 16,540 | 10,006 | 20,622 | 20,503 | 20,693 | 20,381 | 22,068 |
| Book Value Per Share 2 | 8.730 | 9.630 | 9.120 | 9.600 | 9.830 | 10.70 | 11.70 | 12.60 |
| Cash Flow per Share 2 | 2.220 | 2.370 | 2.850 | 2.280 | 1.700 | 2.650 | 2.710 | 2.650 |
| Capex 1 | 105 | 78.3 | 53.3 | 44.9 | 58.1 | 134 | 142 | 160 |
| Capex / Sales | 0.96% | 0.7% | 0.46% | 0.35% | 0.42% | 0.9% | 0.89% | 0.94% |
| Announcement Date | 3/23/20 | 3/23/21 | 3/22/22 | 3/21/23 | 3/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
9.46
CNY
Average target price
13.49
CNY
Spread / Average Target
+42.58%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.54% | 843M | |
| -27.34% | 420M |
- Stock Market
- Equities
- 1112 Stock
- Financials Health and Happiness (H&H) International Holdings Limited
